Intrexon | Lucro Operacional





Lucro Operacional Alterar Data
Agenus USD -13.31M 12.58M 2025-03
Alaunos Therapeutics USD -1.19M 432K 2025-09
Amgen USD 3.96B 464M 2025-12
Anika Therapeutics USD -4.28M 32.1M 2025-03
Arrowhead Research USD 40.81M 3.3M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Heron Therapeutics USD -5.66M 782K 2024-09
Incyte USD 383.88M 47.43M 2025-12
Intrexon USD -60.84M 26.62M 2024-06
Karyopharm Therapeutics USD -31.28M 5M 2024-12
Ligand Pharmaceuticals USD 158.89M 149.17M 2025-09
MacroGenics USD 18.64M 55.4M 2025-09
MannKind USD -41.05M 2.36M 2025-09
Merck USD 6.24B 318M 2025-12
Novartis USD 4.5B 363M 2025-09
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Roche Holding CHF 9.56B 3.8B 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Veracyte USD 23.11M 8.8M 2025-09
Xencor USD -47.52M 14.35M 2025-09


Intrexon Lucro Operacional - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.